… In this study, we investigated the involvement of the TGF-β pathway in the motility of
erlotinib-resistant NSCLC cells and the effects of erlotinib and TGF-βRI inhibition on …

… Comparative effects of gefitinib versus erlotinib on overall survival of patients with non-small
cell lung cancer. Results are presented as individual and pooled HRs with 95% CIs. A HR …

… -small cell lung cancer (NSCLC) patients, however, it is being investigated in all stages of
NSCLC. Erlotinib … The optimization of the therapeutic impact of erlotinib in NSCLC will be more …

… We may have cases in which the antitumor effects are purely through inhibition of EGFR
on tumor cells and other cases in which the antiendothelial effects predominate. …

… In this study, we investigated the effect of erlotinib, an orally … human non-small-cell lung cancer
(NSCLC) cell line NCI-H292. … -H292 cells which was made by inoculating cancer cells into …

… In this study, we investigated the effect of curcumin on the tumor growth of erlotinib-resistant …
the effect of curcumin on NF-κB activation in erlotinib-resistant EGFR-mutant lung cancer …

… erlotinib grafting did not impact the self-assembly process of DNA structures (Fig. 1B).
Transmission electron microscopy (TEM) imaging determined the cubic morphology and uniform …

… We then investigated the effect of CH5164840 on erlotinib activity against … effect of erlotinib
and CH5164840, we examined the antiproliferative effect of the agents on NCI-H1975 cells. …

… the combination of erlotinib with PS indeed exerts additive antineoplastic effects upon the …
mechanisms of action of the combination treatment of PS with erlotinib in NSCLC cell lines …

… The effect of smoking history on erlotinib pharmacokinetics was explored in Study BR.21 [6,
7]. Patients achieved a survival benefit regardless of their smoking history, with HRs for …